Nexans SA (0IGF)
London Stock Exchange · UK · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 122.05 |
|---|---|
| 52-week range | 109.80 – 168.90 |
| Return, 1 month / 3 months | −10.0% / −6.2% |
| Return, 1 year / 3 years | +2.2% / +97.5% |
| Trend | Below its 200-day average |
| RSI (14) | 43 |
| Volatility (1 year) | 36.1% |
| Worst drawdown (1 year) | -31.5% |
| Average daily value traded | 1.70M EUR |
| Dividend yield | 2.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Nexans makes cables and cabling systems for the transmission and distribution of power, as well as cables for telecommunications and data networks. The company supplies utilities, industrial operators, construction firms and infrastructure projects with products ranging from high-voltage power cables to wiring for buildings and transport systems. It is based in France and serves customers in many countries, and it also provides installation and related services alongside its cable products.
The shares are listed on the London Stock Exchange in UK under the code 0IGF, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Nexans SA (0IGF) trades on the London Stock Exchange in UK. It last closed at EUR 122.05 on 27 October 2026.
Its price-based Market X-Ray is 44 out of 100 (a weak price profile), ranking 2,412 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 2.2% and over the last three months it fell 6.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 34 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -9.9% | ||
| From 52-week high | -27.6% | ||
| Momentum | 43 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -6.2% | ||
| 6-month return | -8.7% | ||
| 12-month return, skipping the last month | 13.5% | ||
| Stability (higher is calmer) | 47 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 36.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.5% | ||
| Liquidity | 59 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.70M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 41 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.4% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.9% |
|---|---|
| 1 month | −10.0% |
| 3 months | −6.2% |
| 6 months | −8.7% |
| 1 year | +2.2% |
| 3 years | +97.5% |
| 5 years | +60.7% |
Signals
| 50-day / 200-day average | 133.76 / 135.44 |
|---|---|
| Golden / death cross (60 days) | Death, 3 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.50 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 May 2026 | EUR 2.9000 |
| 19 May 2025 | EUR 2.6000 |
| 21 May 2024 | EUR 2.3000 |
| 15 May 2023 | EUR 2.1000 |
| 16 May 2022 | EUR 1.2000 |
| 19 May 2021 | EUR 0.7000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.